Akari Therapeutics (AKTX) Invested Capital (2011 - 2026)
Akari Therapeutics recorded quarterly Invested Capital of $14.4 million in Q1 2026, down 49.24% quarter-over-quarter from $28.3 million in Q4 2025, and down 33.87% year-over-year from $21.7 million in Q1 2025.
Akari Therapeutics' Invested Capital history runs 16 years deep, the most recent figure standing at $14.4 million for Q1 2026.
- In Q1 2026, Invested Capital fell 33.87% year-over-year to $14.4 million; the TTM figure through Mar 2026 stood at $14.4 million (down 33.87% YoY), while the FY2025 annual figure was $28.3 million, up 27.44% from the prior year.
- Invested Capital came in at $14.4 million for Q1 2026 at Akari Therapeutics, down from $28.3 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $28.3 million in Q4 2025 to a low of -$6.7 million in Q3 2024.
- A 5-year average of $9.6 million and a median of $7.4 million in 2022 frame the typical range for Invested Capital.
- On a YoY basis, Invested Capital climbed as much as 9806.99% in 2024 and fell as far as 3242.72% in 2024.
- Akari Therapeutics' Invested Capital stood at $1.8 million in 2022, then sank by 112.79% to -$229000.0 in 2023, then soared by 9806.99% to $22.2 million in 2024, then advanced by 27.44% to $28.3 million in 2025, then plunged by 49.24% to $14.4 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $14.4 million, $28.3 million, and $22.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.38 Mn |
| Dec 31, 2025 | 28.33 Mn |
| Sep 30, 2025 | 22.69 Mn |
| Jun 30, 2025 | 25.61 Mn |
| Mar 31, 2025 | 21.75 Mn |
| Dec 31, 2024 | 22.23 Mn |
| Sep 30, 2024 | -6.69 Mn |
| Jun 30, 2024 | -3.70 Mn |
| Mar 31, 2024 | -3.55 Mn |
| Dec 31, 2023 | -229,000.00 |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 2.78 Mn |
| Mar 31, 2023 | 6.56 Mn |
| Dec 31, 2022 | 1.79 Mn |
| Jun 30, 2022 | 8.33 Mn |
| Mar 31, 2022 | 13.93 Mn |
| Dec 31, 2021 | 5.56 Mn |
| Sep 30, 2021 | 11.36 Mn |
| Jun 30, 2021 | 1.59 Mn |
| Mar 31, 2021 | 3.94 Mn |
| Sep 30, 2020 | 6.95 Mn |
| Jun 30, 2020 | 5.96 Mn |
| Mar 31, 2020 | 3.27 Mn |
| Dec 31, 2019 | 7,598.00 |
| Sep 30, 2019 | 4.90 Mn |
| Jun 30, 2019 | 459,367.00 |
| Mar 31, 2019 | 4.84 Mn |
| Dec 31, 2018 | 4.37 Mn |
| Sep 30, 2018 | 128.90 Mn |
| Jun 30, 2018 | 22.93 Mn |
| Mar 31, 2018 | -203,447.00 |
| Dec 31, 2017 | 22.24 Mn |
| Sep 30, 2017 | 13.04 Mn |
| Jun 30, 2017 | 22.85 Mn |
| Mar 31, 2017 | 22.40 Mn |
| Dec 31, 2016 | 34.10 Mn |
| Sep 30, 2016 | 41.04 Mn |
| Jun 30, 2016 | 40.58 Mn |
| Mar 31, 2016 | 46.36 Mn |
| Dec 31, 2015 | 48.72 Mn |
| Sep 30, 2015 | 41.33 Mn |
| Jun 30, 2015 | 973,000.00 |
| Mar 31, 2015 | 2.60 Mn |
| Dec 31, 2014 | 2.22 Mn |
| Jun 30, 2014 | 10.42 Mn |
| Dec 31, 2013 | 400,690.00 |
| Dec 31, 2012 | -3.36 Mn |
| Dec 31, 2011 | -2.49 Mn |